HIV & AIDS

Trim the sugar: New HIV vaccine design improves immune response

A new HIV vaccine from Scripps Research has shown a significantly improved ability to neutralize the virus in preclinical tests, and it will soon be studied in healthy people who volunteer to participate in clinical trials.

HIV & AIDS

Researchers develop simple, affordable HIV testing device

HIV is one of the world's most serious public health challenges, and molecular detection plays a significant role in early diagnosis and antiretroviral therapy for HIV patients. The current "gold standard" of HIV testing ...

Diseases, Conditions, Syndromes

Researcher identifies potential cause of 'long COVID'

Even though the COVID-19 public health emergency classification will expire this spring, the lingering effects of the pandemic remain. A constant puzzle to solve since the first year of the pandemic has been "long COVID," ...

page 6 from 40